Holen Sie sich die Stockscreener-App
18.79
0.70%
-0.1328
Schlusskurs vom Vortag:
$18.92
Offen:
$17.67
24-Stunden-Volumen:
1.14M
Relative Volume:
0.76
Marktkapitalisierung:
$927.59M
Einnahmen:
$230.59M
Nettoeinkommen (Verlust:
$-96.37M
KGV:
-9.5995
EPS:
-1.9571
Netto-Cashflow:
$-39.54M
1W Leistung:
-6.67%
1M Leistung:
+7.12%
6M Leistung:
-32.37%
1J Leistung:
+5.85%
1-Tages-Spanne:
$17.56
$19.44
1-Wochen-Bereich:
$17.56
$20.38
52-Wochen-Spanne:
$14.69
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
18.79 | 934.00M | 230.59M | -96.37M | -39.54M | -1.9571 |
|
ISRG
Intuitive Surgical Inc
|
504.60 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.32 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.73 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.41 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.30 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-03 | Eingeleitet | Wedbush | Neutral |
| 2026-01-16 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
STAAR Surgical (NASDAQ:STAA) Shares Gap Down Following Weak Earnings - MarketBeat
STAA Analyst Rating Update: Stifel Lowers Price Target | STAA St - GuruFocus
Stifel Nicolaus Issues Pessimistic Forecast for STAAR Surgical (NASDAQ:STAA) Stock Price - MarketBeat
A Glimpse Into The Expert Outlook On Staar Surgical Through 7 Analysts - Benzinga
Stifel cuts Staar Surgical stock price target on weak Q4 results - Investing.com
Canaccord reiterates Hold on STAAR Surgical stock, $22 target - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
STAAR Surgical earnings missed by $0.52, revenue topped estimates - Investing.com South Africa
Staar Surgical Co (STAA) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
STAAR Surgical Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: STAAR Surgical Q4 2025 misses EPS forecast, stock dips - Investing.com
Staar Surgical co-CEOs address shareholders, poor Q4 earnings - MassDevice
STAA Reports Lower Q4 Revenue Amidst Inventory Adjustments and M - GuruFocus
Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates - Yahoo Finance UK
STAAR Surgical Co reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (STAA) STAAR Surgical Posts Q4 Loss of $0.37, vs. FactSet Est EPS of $0.04 - marketscreener.com
STAAR Surgical names interim co-CEOs, targets 2026 growth - Investing.com India
STAAR Surgical (NASDAQ:STAA) Misses Q4 CY2025 Sales Expectations, Stock Drops 11.2% - Bitget
STAAR Surgical (NASDAQ:STAA) Issues Earnings Results - MarketBeat
Staar Surgical: Q4 Earnings Snapshot - Bitget
Staar Surgical reports Q4 EPS 0c, consensus 17c - TipRanks
Earnings Breakdown: Staar Surgical Q4 - Benzinga
STAAR Surgical stock plunges 12% on unexpected Q4 loss By Investing.com - Investing.com Australia
STAAR Surgical Company (STAA) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Earnings Flash (STAA) STAAR Surgical Company Reports Q4 Revenue $57.8M, vs. FactSet Est of $75.0M - marketscreener.com
STAAR Surgical (NASDAQ: STAA) revenue falls in 2025 as China reset widens losses - Stock Titan
Eye implant maker targets China rebound and older patients in 2026 - Stock Titan
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results - Yahoo Finance Singapore
[10-K] STAAR SURGICAL CO Files Annual Report | STAA SEC FilingForm 10-K - Stock Titan
STAAR Surgical Co. Experiences Evaluation Revision Amidst Fluctuating Market Conditions - Markets Mojo
An Inside Look at the Alcon-STAAR Surgical Deal Collapse - Medical Product Outsourcing
Midday Stock Roundup: Ingram Micro’s Shares Jump After Q4 Results - Orange County Business Journal
What's Next: Staar Surgical's Earnings Preview - Benzinga
STAAR Surgical Company (NASDAQ:STAA) Short Interest Update - MarketBeat
STAAR Surgical Co. Hits Day High with 11.2% Surge in Stock Price - Markets Mojo
STAA SEC FilingsStaar Surg 10-K, 10-Q, 8-K Forms - Stock Titan
STAA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
STAAR Surgical reaches 4 million lens sales milestone By Investing.com - Investing.com Australia
STAAR Surgical reaches 4 million lens sales milestone - Investing.com
STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction - Yahoo Finance
STAAR Surgical (NASDAQ:STAA) Trading Up 8.4%Here's What Happened - MarketBeat
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026 - marketscreener.com
Eye lens maker STAAR Surgical sets March 3 call on 2025 results, China recovery - Stock Titan
FDA expands age indication for STAAR’s EVO ICL to patients aged 21–60 years - Optometry Times
STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Amidst a 27.10% Potential Upside - DirectorsTalk Interviews
FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs - Eyes On Eyecare
STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years - Yahoo Finance
FDA approved expanded age indication for EVO/EVO+ Visian implantable lenses - TipRanks
FDA Approves Expanded Age Range for STAAR Surgical’s EVO ICL for Vision Correction - VisionMonday.com
Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens - Eyes On Eyecare
FDA expands age indication for Staar Surgical EVO ICL - MassDevice
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Staar Surgical Co-Aktie (STAA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 09 '26 |
Buy |
22.05 |
27,485 |
606,138 |
15,453,629 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 06 '26 |
Buy |
21.62 |
336,946 |
7,284,281 |
15,356,437 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 07 '26 |
Buy |
22.00 |
66,467 |
1,462,301 |
15,422,904 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 08 '26 |
Buy |
21.94 |
3,240 |
71,082 |
15,426,144 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 21 '25 |
Buy |
27.86 |
797,486 |
22,218,837 |
15,019,491 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 20 '25 |
Buy |
27.14 |
393,382 |
10,675,325 |
14,222,005 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 19 '25 |
Buy |
26.42 |
309,132 |
8,166,155 |
13,828,623 |
| Jiang Wei | Director |
Nov 12 '25 |
Option Exercise |
0.00 |
20,967 |
0 |
45,477 |
| Jiang Wei | Director |
Aug 12 '25 |
Option Exercise |
0.00 |
20,967 |
0 |
24,510 |
1.26%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):